Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Quattroflow™ Introduces 5050 Series Quaternary Diaphragm Pumps

Published: Tuesday, May 14, 2013
Last Updated: Tuesday, May 14, 2013
Bookmark and Share
Ideal for use in demanding biotech and pharmaceutical applications.

Quattroflow™ has announced the introduction of its 5050 Series Quaternary Diaphragm Pump to its family of biotech and pharmaceutical pumps.

This innovative pump system features compact dimensions, multi-directional connections and the ability to satisfy a wide variety of flow-rate requirements, which makes it ideal for use in demanding biotech and pharmaceutical applications.

The 5050 pump provides multi-option installation flexibility and a compact design. The unit is drainable and cleanable, and includes multi-directional pump-head connections and positioning.

The 5050 pump features a 225mm (8.86”) chamber diameter and 50mm (1-1/2”) flange porting.

The 5050 pump has a wide flow range from 50 to 5,000 L/hr (13 to 1,321 gph), with maximum pressure to 6 bar at 20°C (87 psi at 68°F). The complete flow range can be achieved with one drive, no further drive options needed.

The pump chamber is available in 316L stainless steel for multiple-use and polypropylene (PP) for single-use applications. The pump’s valves are constructed of EPDM, while the diaphragm is Santoprene® (EPDM/PP compound).

Quattroflow’s positive displacement pumps incorporate a four piston-diaphragm technology with no mechanical seals that is driven by an eccentric shaft and motor.

Quattroflow products primarily serve the biotech and pharmaceutical industries that require gentle displacement, reliability, product safety, purity and cleanability.

The 5050 pump can be found in multiple or single-use applications within cross-flow systems, chromatography devices and centrifuges.

Quattroflow is a leading brand from Almatec, which is part of Dover Corporation’s Pump Solutions Group (PSG®).


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!